Skip to content

Evaluation of Axillary Lymph Node Metastasis Status of Breast Cancer Based on Pathological Images and Virtual Staining

Evaluation of Axillary Lymph Node Metastasis Status of Breast Cancer Based on Pathological Images and Virtual Staining

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06486155
Enrollment
2200
Registered
2024-07-03
Start date
2024-08-31
Completion date
2025-12-31
Last updated
2024-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Digital Pathology, Lymph Node Metastasis, Virtual Staining

Brief summary

The goal of this observational study is to develop an artificial intelligence model to transform unstained lymph node tissue slice images directly into stained images. The main questions it aims to answer are: Can the virtual staining model generate hematoxylin and eosin (H&E) and immunohistochemistry (IHC) images suitable for clinical diagnosis from unstained paraffin-embedded lymph node slice images, including those from breast axillary lymph nodes and other tumor lymph nodes? Can the virtual staining model generate H&E and IHC images suitable for clinical diagnosis from unstained frozen sentinel lymph node slice images from breast cancer patients? Researchers will retrospectively collect paraffin-embedded lymph node slices from tumor patients and prospectively collect frozen sentinel lymph node slices from breast cancer patients.

Interventions

None listed

Sponsors

Affiliated Cancer Hospital of Shantou University Medical College
CollaboratorOTHER
Yunnan Cancer Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

Part 1: Female patients aged 18-75 with breast cancer; Undergoing surgical excision of breast cancer and sentinel lymph node biopsy/axillary lymph node dissection; Lymph nodes with clear postoperative paraffin pathological results. Part 2: Patients aged 18-75 with one of the following cancers: thyroid, lung, esophagus, stomach, colorectal, prostate, bladder, or cervix; Undergoing surgical resection of lymph nodes; Lymph nodes with clear postoperative paraffin pathological results. Part 3: Female patients aged 18-75 with breast cancer; Undergoing surgical excision of breast cancer and sentinel lymph node biopsy; Sentinel lymph nodes with clear postoperative paraffin pathological results.

Exclusion criteria

Part 1 / Part 2: Lymph node diagnosis is missing; Absence of lymph node component in the slice. Part 3: Sentinel lymph node diagnosis is missing; Absence of lymph node component in the frozen slice.

Design outcomes

Primary

MeasureTime frameDescription
Lymph node metastasis status2024-2025Lymph node metastasis status: metastasis or non-metastasis
Accuracy, Sensitivity, Specificity,Area under the curve,2024-2025The performance of pathologists diagnosing the lymph node metastasis status by virtual and real staining whole slide images
Positive predictive value,Negative predictive value2024-2025The performance of pathologists diagnosing the lymph node metastasis status by virtual and real staining whole slide images

Secondary

MeasureTime frameDescription
Peak Signal-to-Noise Ratio(PSNR)2024-2025Scores of the similarity between virtual and real staining of lymph nodes, with values ranging from 0 to infinity, the higher scores mean the better outcomes
Multi-Scale Structural Similarity (MS-SSIM)2024-2025Scores of the similarity between virtual and real staining of lymph nodes, with values ranging from 0 to 1, the higher scores mean the better outcomes
Pearson correlation coefficient2024-2025Scores of the similarity between virtual and real staining of lymph nodes, with values ranging from 0 to 1, the higher scores mean the better outcomes

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026